McDonald, S. The Mental Elf Blog. Published online 28 April 2016
Mindfulness-Based Cognitive Therapy (MBCT) has gained traction as a therapy for the many people whose lives are blighted by recurrent depression. As a potential alternative to antidepressants or other proven talking therapies, MBCT has the dual attractions of apparent clinical efficacy and cost effectiveness (Kuyken et al, 2015).
As a therapy that has really developed over the last twenty years or so, a time during which momentum has gathered behind proving through research the evidence base for therapies, MBCT has a considerable number of research papers (especially well-conducted randomised trials) behind it in comparison to other models of therapy.
Commentary of: Kuyken W. et al. Efficacy and moderators of mindfulness-based cognitive therapy (MBCT) in prevention of depressive relapse: An individual patient data meta-analysis from randomized trials. JAMA Psychiatry. Published online April 27, 2016
Summary
- This meta-analysis adds further impetus to the drive to make MBCT a therapy of choice for relapsing depression.
- It certainly presents a strong case for clinicians to provide MBCT for individuals with a substantial history of relapsing depression.
- The finding that MBCT was more therapeutic for people with higher levels of depression but still conferred some benefit and did not appear to have adverse effects on people with less severe symptoms is helpful for those planning mental health services or considering national guidance.
Read full commentary here
Read original research abstract here
Public Health News 